Perkins Coie Trust Company’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50K Sell
639
-38,106
-98% -$3.07M 0.01% 163
2026
Q1
$3.36M Sell
38,745
-556
-1% -$53.3K 0.65% 42
2025
Q4
$3.78M Sell
39,301
-684
-2% -$66.4K 0.7% 40
2025
Q3
$3.81M Sell
39,985
-1,115,440
-97% -$103M 0.72% 41
2025
Q2
$101M Buy
1,155,425
+1,117,570
+2,952% +$94.8M 17.15% 1
2025
Q1
$3.4M Sell
37,855
-374
-1% -$33.5K 0.77% 45
2024
Q4
$3.05M Sell
38,229
-749
-2% -$64.8K 0.67% 48
2024
Q3
$3.51M Buy
38,978
+348
+0.9% +$29.3K 0.78% 45
2024
Q2
$3.04M Buy
38,630
+382
+1% +$31.3K 0.71% 47
2024
Q1
$3.33M Buy
38,248
+1,312
+4% +$112K 0.78% 44
2023
Q4
$3.04M Buy
36,936
+27
+0.1% +$2.06K 0.77% 45
2023
Q3
$2.89M Buy
36,909
+2,739
+8% +$229K 0.82% 43
2023
Q2
$3.01M Sell
34,170
-422
-1% -$36.3K 0.86% 42
2023
Q1
$2.79M Buy
34,592
+1,712
+5% +$140K 0.84% 43
2022
Q4
$2.56M Sell
32,880
-202
-0.6% -$16.4K 0.82% 44
2022
Q3
$2.67M Sell
33,082
-861
-3% -$77.4K 1.02% 38
2022
Q2
$3.05M Sell
33,943
-9
-0% -$912 1.11% 38
2022
Q1
$3.77M Sell
33,952
-1,145
-3% -$121K 1.17% 35
2021
Q4
$3.63M Buy
35,097
+1,450
+4% +$168K 1.06% 38
2021
Q3
$4.22M Sell
33,647
-883
-3% -$114K 1.32% 30
2021
Q2
$4.29M Buy
34,530
+528
+2% +$66.3K 1.32% 30
2021
Q1
$4.02M Buy
34,002
+215
+0.6% +$25.2K 1.34% 31
2020
Q4
$3.96M Buy
33,787
+808
+2% +$88.9K 1.35% 28
2020
Q3
$3.43M Buy
32,979
+968
+3% +$97.2K 1.37% 28
2020
Q2
$2.94M Buy
32,011
+1,274
+4% +$122K 1.21% 31
2020
Q1
$2.77M Sell
30,737
-943
-3% -$100K 1.41% 20
2019
Q4
$3.59M Buy
31,680
+1,289
+4% +$141K 1.47% 20
2019
Q3
$3.3M Buy
30,391
+10
+0% +$1.04K 1.46% 17
2019
Q2
$2.96M Sell
30,381
-654
-2% -$59.7K 1.34% 23
2019
Q1
$2.83M Buy
31,035
+89
+0.3% +$7.97K 1.31% 23
2018
Q4
$2.81M Buy
30,946
+5
+0% +$467 1.47% 19
2018
Q3
$3.04M Sell
30,941
-50
-0.2% -$4.62K 1.41% 19
2018
Q2
$2.65M Buy
30,991
+425
+1% +$35.5K 1.31% 23
2018
Q1
$2.45M Buy
30,566
+2,096
+7% +$173K 1.22% 27
2017
Q4
$2.3M Buy
28,470
+877
+3% +$70.2K 1.15% 31
2017
Q3
$2.15M Buy
27,593
+448
+2% +$37.2K 1.11% 34
2017
Q2
$2.41M Buy
27,145
+582
+2% +$49.1K 1.3% 28
2017
Q1
$2.14M Sell
26,563
-178
-0.7% -$13.9K 1.26% 30
2016
Q4
$1.9M Buy
26,741
+601
+2% +$47.2K 1.16% 36
2016
Q3
$2.26M Buy
26,140
+1,382
+6% +$120K 1.43% 25
2016
Q2
$2.15M Buy
24,758
+210
+0.9% +$17K 1.42% 27
2016
Q1
$1.84M Sell
24,548
-883
-3% -$66.5K 1.25% 30
2015
Q4
$1.96M Buy
25,431
+316
+1% +$23.8K 1.47% 26
2015
Q3
$1.68M Buy
25,115
+660
+3% +$48.6K 1.35% 30
2015
Q2
$1.81M Buy
24,455
+1,809
+8% +$138K 1.37% 31
2015
Q1
$1.77M Buy
22,646
+21,746
+2,416% +$1.65M 1.36% 31
2014
Q4
$65K Hold
900
0.05% 107
2014
Q3
$56K Hold
900
0.05% 114
2014
Q2
$57K Hold
900
0.05% 106
2014
Q1
$55K Buy
900
+400
+80% +$23.3K 0.05% 105
2013
Q4
$29K Buy
+500
New +$28.4K 0.03% 136

Other funds holding MDT

Perkins Coie Trust Company's MDT Position: Q2 2026 in Review

Perkins Coie Trust Company reduced its Medtronic (MDT) stake by 98% in Q2 2026, selling an estimated $3.07M and leaving 639 shares worth $50K. The position accounts for 0.01% of the portfolio, ranked #163.

Perkins Coie Trust Company first reported a position in MDT in Q4 2013 and has held it in 51 quarters since. The position peaked at $101M in Q2 2025. 673 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Perkins Coie Trust Company held 639 shares of Medtronic worth $50K as of Q2 2026.
  • Perkins Coie Trust Company sold 38,106 Medtronic shares in Q2 2026, an estimated $3.07M.
  • Medtronic made up 0.01% of Perkins Coie Trust Company's portfolio in Q2 2026, its #163 holding.
  • Perkins Coie Trust Company first reported a position in Medtronic in Q4 2013 and has held it in 51 quarters since.
  • Perkins Coie Trust Company's Medtronic position peaked at $101M in Q2 2025.
  • 673 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Perkins Coie Trust Company's 13F filing for Q2 2026, filed 9 Jul 2026.